Brain delivery of an amyloid-β oligomer (AβO)-targeting peptide-therapeutic by a novel blood-brain barrier (BBB)-crossing domain antibody

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.jalz.2017.06.703
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Abstract
Publication date
PublisherElsevier
In
LanguageEnglish
Peer reviewedYes
NPARC number23002450
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier16c5c6bb-33b2-4d89-a2ed-f5f67cceeacd
Record created2017-11-10
Record modified2020-03-16
Date modified: